Header Logo

Connection

Xinli Liu to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications Xinli Liu has written about Cell Line, Tumor.
Xinli Liu
Connection Strength
0.053
Cell Line, Tumor
  1. MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer. 2024 Sep 23; 12(9).
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.